Neurocrine Biosciences
NBIX
#1401
Rank
$12.48 B
Marketcap
$123.29
Share price
3.49%
Change (1 day)
12.67%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024 (TTM): $0.65 Billion USD

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are $2.24 Billion USD. In 2023 the company made an earning of $0.35 Billion USD, an increase over its 2022 earnings that were of $0.22 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) $0.65 B82.47%
2023 $0.35 B62.85%
2022 $0.22 B73.74%
2021 $0.12 B-8.82%
2020 $0.13 B77.78%
2019 $78.46 M49.83%
2018 $52.37 M-142.57%
2017 -$0.13 Billion-14.73%
2016 -$0.15 Billion53.15%
2015 -$94.21 Million46.25%
2014 -$64.42 Million29.66%
2013 -$49.68 Million-3530.8%
2012 $1.44 M-95.73%
2011 $33.92 M
2009 -$47.69 Million-45.38%
2008 -$87.3 Million-58.87%
2007 -$0.22 Billion87.3%
2006 -$0.12 Billion351.97%
2005 -$25.08 Million-52.09%
2004 -$52.34 Million-10.98%
2003 -$58.79 Million
2001 -$43.89 Million
1999 -$19.79 Million108.32%
1998 -$9.5 Million
1996 $2.9 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$21.45 M-96.73%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.21 B 85.21%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$30.41 Million-104.63%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.15 B 1,445.68%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.06 B 975.99%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.22 Billion-284.56%๐Ÿ‡บ๐Ÿ‡ธ USA
$35.5 M-94.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-$41.77 Million-106.36%๐Ÿ‡บ๐Ÿ‡ธ USA